Hedge Fund - Aquilo Capital Management
Spero Therapeutics Inc. (SPRO)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2022 - Q4 (2022-12-31) | $0 | 0% | 0 | $1.87 |
| 2 | 2022 - Q3 (2022-09-30) | $6,806,000 | 2.45% | 3,403,210 | $0.99 |
| 3 | 2022 - Q2 (2022-06-30) | $3,943,000 | 1.34% | 5,321,231 | $2.91 |
| 4 | 2022 - Q1 (2022-03-31) | $45,949,000 | 6.75% | 5,281,504 | $10.25 |
| 5 | 2021 - Q4 (2021-12-31) | $79,477,000 | 9.01% | 4,964,181 | $15.88 |
| 6 | 2021 - Q3 (2021-09-30) | $84,017,000 | 15.25% | 4,563,688 | $16.05 |
| 7 | 2021 - Q2 (2021-06-30) | $53,456,000 | 13.88% | 3,829,209 | $13.97 |
| 8 | 2021 - Q1 (2021-03-31) | $56,366,000 | 10.18% | 3,829,209 | $17.60 |
| 9 | 2020 - Q4 (2020-12-31) | $76,246,000 | 15.84% | 3,932,209 | $15.59 |
| 10 | 2020 - Q3 (2020-09-30) | $50,188,000 | 5.31% | 4,497,142 | $11.83 |
| 11 | 2020 - Q2 (2020-06-30) | $26,290,000 | 5.3% | 1,943,081 | $11.23 |
| 12 | 2020 - Q1 (2020-03-31) | $14,691,000 | 5.72% | 1,818,140 | $8.81 |
| 13 | 2019 - Q4 (2019-12-31) | $11,099,000 | 4.16% | 1,154,356 | $10.78 |
| 14 | 2019 - Q3 (2019-09-30) | $12,236,000 | 8.61% | 1,154,356 | $10.54 |
| 15 | 2019 - Q2 (2019-06-30) | $13,287,000 | 4.61% | 1,154,356 | $12.04 |
| 16 | 2019 - Q1 (2019-03-31) | $13,506,000 | 5.97% | 1,054,356 | $10.61 |
| 17 | 2018 - Q4 (2018-12-31) | $6,346,000 | 3.07% | 1,031,947 | $8.10 |
| 18 | 2018 - Q3 (2018-09-30) | $8,405,000 | 3.51% | 799,691 | $11.61 |
| 19 | 2018 - Q2 (2018-06-30) | $6,112,000 | 5.04% | 416,691 | $12.79 |
The displayed share prices are average quarterly stock market prices.